Managing Expectations: "We're Still On Target" Says AstraZeneca CEO

 
• By Sten Stovall
  
Pascal Soriot
Pascal Soriot Says AstraZeneca Still On Course To Hit 2023 Sales Target • Source: Scrip/LEllis

More from Clinical Trials

More from R&D